156 related articles for article (PubMed ID: 25619520)
1. Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.
Klier J; Lehmann B; Fuchs S; Reese S; Hirschmann A; Coester C; Winter G; Gehlen H
J Vet Intern Med; 2015 Jan; 29(1):286-93. PubMed ID: 25619520
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles.
Klier J; May A; Fuchs S; Schillinger U; Plank C; Winter G; Gehlen H; Coester C
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):79-87. PubMed ID: 21831455
[TBL] [Abstract][Full Text] [Related]
3. A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma-affected horses, an animal model.
Klier J; Geis S; Steuer J; Geh K; Reese S; Fuchs S; Mueller RS; Winter G; Gehlen H
Immun Inflamm Dis; 2018 Mar; 6(1):81-96. PubMed ID: 29094511
[TBL] [Abstract][Full Text] [Related]
4. A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses.
Klier J; Fuchs S; May A; Schillinger U; Plank C; Winter G; Coester C; Gehlen H
Pharm Res; 2012 Jun; 29(6):1650-7. PubMed ID: 22302522
[TBL] [Abstract][Full Text] [Related]
5. Owner-reported coughing and nasal discharge are associated with clinical findings, arterial oxygen tension, mucus score and bronchoprovocation in horses with recurrent airway obstruction in a field setting.
Rettmer H; Hoffman AM; Lanz S; Oertly M; Gerber V
Equine Vet J; 2015 May; 47(3):291-5. PubMed ID: 24761754
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect.
Klier J; Bartl C; Geuder S; Geh KJ; Reese S; Goehring LS; Winter G; Gehlen H
Immun Inflamm Dis; 2019 Sep; 7(3):130-149. PubMed ID: 31141308
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
Matera MG; Calzetta L; Rogliani P; Bardaro F; Page CP; Cazzola M
Pulm Pharmacol Ther; 2011 Apr; 24(2):221-6. PubMed ID: 21195788
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-butylscopolammonium bromide on lung function in horses with recurrent airway obstruction.
Couetil L; Hammer J; Miskovic Feutz M; Nogradi N; Perez-Moreno C; Ivester K
J Vet Intern Med; 2012; 26(6):1433-8. PubMed ID: 22925156
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma.
Barton AK; Shety T; Klier J; Geis S; Einspanier R; Gehlen H
Mediators Inflamm; 2019; 2019():7845623. PubMed ID: 31316303
[TBL] [Abstract][Full Text] [Related]
10. Towards an inhalative in vivo application of immunomodulating gelatin nanoparticles in horse-related preformulation studies.
Fuchs S; Klier J; May A; Winter G; Coester C; Gehlen H
J Microencapsul; 2012; 29(7):615-25. PubMed ID: 22432849
[TBL] [Abstract][Full Text] [Related]
11. Response to nasopharyngeal oxygen administration in horses with lung disease.
Wilson DV; Schott HC; Robinson NE; Berney CE; Eberhart SW
Equine Vet J; 2006 May; 38(3):219-23. PubMed ID: 16706275
[TBL] [Abstract][Full Text] [Related]
12. Pilot study investigating the ability of an herbal composite to alleviate clinical signs of respiratory dysfunction in horses with recurrent airway obstruction.
Pearson W; Charch A; Brewer D; Clarke AF
Can J Vet Res; 2007 Apr; 71(2):145-51. PubMed ID: 17479778
[TBL] [Abstract][Full Text] [Related]
13. Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction.
Horohov DW; Beadle RE; Mouch S; Pourciau SS
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):237-45. PubMed ID: 16098607
[TBL] [Abstract][Full Text] [Related]
14. Telemetric analysis of breathing pattern variability in recurrent airway obstruction (heaves)-affected horses.
Behan AL; Hauptman JG; Robinson NE
Am J Vet Res; 2013 Jun; 74(6):925-33. PubMed ID: 23718662
[TBL] [Abstract][Full Text] [Related]
15. Clinical Research Abstracts of the British Equine Veterinary Association Congress 2015.
Klier J; Geis S; Steuer J; Reese S; Fuchs S; Mueller RS; Winter G; Gehlen H
Equine Vet J; 2015 Sep; 47 Suppl 48():26. PubMed ID: 26375616
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate aerosol is more effective for prevention than treatment of recurrent airway obstruction.
Robinson NE; Berney C; Behan A; Derksen FJ
J Vet Intern Med; 2009; 23(6):1247-53. PubMed ID: 19747193
[TBL] [Abstract][Full Text] [Related]
17. Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction.
Couëtil LL; Art T; de Moffarts B; Becker M; Mélotte D; Jaspar F; Bureau F; Lekeux P
J Vet Intern Med; 2006; 20(2):399-406. PubMed ID: 16594601
[TBL] [Abstract][Full Text] [Related]
18. The effect of adding oral dexamethasone to feed alterations on the airway cell inflammatory gene expression in stabled horses affected with recurrent airway obstruction.
DeLuca L; Erb HN; Young JC; Perkins GA; Ainsworth DM
J Vet Intern Med; 2008; 22(2):427-35. PubMed ID: 18346142
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction.
Laan TT; Bull S; Pirie RS; Fink-Gremmels J
Vet J; 2006 May; 171(3):429-37. PubMed ID: 16624708
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
